You'll have an easier time figuring out which plan best suits you if you understand some of the major changes coming to ...

British Columbians are heading to Thailand for addiction treatment, driven by a public health system stretched to its limits ...

Major changes in 2025 include Medicare Advantage plans and a new $2,000 out-of-pocket max under Part D, eliminating "donut ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Alongside biosimilars, Beneva has forged product listing agreements that offer a 12% average discount on more than 50 ...

Multnomah County officials say 91 people have started a new drug addiction program, but the outcomes remain unclear.

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...

Seattle Mayor Bruce Harrell is set to unveil a new initiative Friday aimed at enhancing safety on the city's streets.

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...